SUN PHARMACEUTICAL IND L vs VAISHALI PHARMA LIMITED

A side-by-side comparison of SUN PHARMACEUTICAL IND L (SUNPHARMA) and VAISHALI PHARMA LIMITED (VAISHALI) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, SUN PHARMACEUTICAL IND L leads SUNPHARMA vs VAISHALI on 10 of 14 metrics (2 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

40.40
P/E ratio
24.50
5.57
P/B ratio
1.36
0.83%
Dividend yield
0.00%
₹47.84
EPS
₹0.32

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

16.00%
Return on equity
6.02%
21.00%
Return on capital
4.02%
30.00%
EBITDA margin
4.00%
19.69%
Net margin
3.67%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.03%
Revenue CAGR (3Y)
10.57%
Profit CAGR (3Y)

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹4.64L Cr
Market cap
₹0 Cr
₹58,462 Cr
Revenue
₹109 Cr
₹11,509 Cr
Net profit
₹4 Cr
0.06
Debt / equity
0.28
SUN PHARMACEUTICAL IND L
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
  • ["The company has delivered a poor sales growth of 11.8% over past five years."]
VAISHALI PHARMA LIMITED
  • ["Promoter holding is low: 31.6%", "Earnings include an other income of Rs.3.84 Cr.", "Company has high debtors of 170 days."]
SUN PHARMACEUTICAL IND L full analysis VAISHALI PHARMA LIMITED full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.